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Uterine receptivity to embryo implantation is coordi-
nately regulated by 17b-estradiol (E2) and proges-
terone (P4). Although increased E2 sensitivity causes
infertility, the mechanisms underlying the modulation
of E2 sensitivity are unknown. We show that nuclear
receptor coactivator-6 (NCOA6), a reported coactiva-
tor for estrogen receptor a (ERa), actually attenuates
E2 sensitivity to determine uterine receptivity to
embryo implantation under normal physiological con-
ditions. Specifically, conditional knockout of Ncoa6 in
uterine epithelial and stromal cells does not decrease,
but rather markedly increases E2 sensitivity, which
disrupts embryo implantation and inhibits P4-regu-
lated genes and decidual response. NCOA6 enhances
ERa ubiquitination and accelerates its degradation,
while loss of NCOA6 causes ERa accumulation in
stromal cellsduring thepreimplantationperiod.During
the same period, NCOA6 deficiency also caused a
failure in downregulation of steroid receptor coactiva-
tor-3 (SRC-3), a potent ERa coactivator. Therefore,
NCOA6 controls E2 sensitivity and uterine receptivity
by regulating multiple E2-signaling components.
INTRODUCTION
Embryo implantation depends on molecular interactions
between the hormone-primed uterus and the mature blastocyst
(Wang and Dey, 2006). Implantation failure can be caused by
defects in embryo or endometrium (Cakmak and Taylor, 2011;
Valbuena et al., 1999). The endometrium is receptive to blasto-
cyst implantation only in a restricted time ‘‘window’’ (Cakmak
and Taylor, 2011; Wang and Dey, 2006), which is determined
by the spatiotemporal regulation of the proliferation and differen-
tiation status of uterine epithelial cells (ECs) and stromal cells
(SCs) in response to progesterone (P4) and 17b-estradiol (E2)
stimuli. Upon P4 priming during early mouse pregnancy, a small
and temporal E2 increase at 3.5 days postcoitum (dpc) is essen-
tial for further induction of uterine SC proliferation and luminal EC
differentiation to prepare the uterus for blastocyst attachment at
4.0 dpc (Matsumoto et al., 2002; Wang and Dey, 2006).
E2 action is mediated by estrogen receptors a and b (ERa and
ERb, respectively). Studies using ERa and ERb knockout (KO)858 Developmental Cell 23, 858–865, October 16, 2012 ª2012 Elsevmice have shown that ERa, but not ERb, is essential for
preparing endometrium for blastocyst attachment, while both
receptors may be dispensable for P4-induced uterine deciduali-
zation (Wang and Dey, 2006). Furthermore, tightly regulated E2
concentrations determine the duration of receptive time window
in the uterus. Lower E2 levels sustain but higher E2 levels shut
down this time window (Ma et al., 2003). Although the exact
role of E2 at the preimplantation stage is unclear in human uterus
(Wang and Dey, 2006), high serum E2 levels or E2/P4 ratios
induced by artificial ovulation inductionmay generate an adverse
endometrial environment and reduce implantation rate (Val-
buena et al., 1999). Failure of ERa downregulation at the
implantation stage may also increase E2 sensitivity and reduce
the pregnancy rate in women with polycystic ovary syndrome
(PCOS) (Gregory et al., 2002).
NCOA6 (AIB3, ASC-2, RAP250, NRC, PRIP, or TRBP) is a re-
ported coactivator for multiple nuclear receptors and has many
biological functions (Mahajan and Samuels, 2005). Ncoa6 KO
inmice causes embryonic lethality due to developmental defects
in placenta, heart, and liver (Kuang et al., 2002; Mahajan and
Samuels, 2005). In cultured cells, NCOA6 interacts with ERa
and enhances its transcriptional function (Caira et al., 2000;
Ko et al., 2000; Lee et al., 1999; Mahajan and Samuels, 2000).
NCOA6 contains two LXXLL motifs, and ERa mainly interacts
with its N-terminal LXXLL motif (Mahajan and Samuels, 2005).
Ncoa6 is expressed in many tissues, including uterine ECs and
SCs (Zhang et al., 2003). The female heterozygous Ncoa6 KO
mice exhibit a slightly reduced reproductive function (Mahajan
and Samuels, 2005). However, the physiological function and
molecular mechanisms for NCOA6 during early pregnancy are
unknown. In this study, we defined the function of Ncoa6 in
early pregnancy by conditional KO of Ncoa6 in the progesterone
receptor (PR)-positive cell lineages in mice, including both ECs
and SCs in the uterus. We demonstrate that the essential
role of NCOA6 as a ‘‘coactivator’’ in uterine receptivity is actually
to attenuate E2 sensitivity through accelerating ERa ubiquitina-
tion and degradation and downregulating SRC-3 in the endome-
trial epithelium at the preimplantation stage.
RESULTS
Conditional Deletion of the Ncoa6 Gene in the Mouse
Uterus, Corpus Luteum, and Fallopian Tube Causes
a Failure of Embryo Attachment
SinceNcoa6 null mice display embryonic lethality, we generated
the floxed Ncoa6 (Ncoa6f/f) mice, which were as normal asier Inc.
Figure 1. Ncoa6d/d Mice Are Infertile and Exhibit Altered Expression Patterns of P4 and E2-Inducible Genes in the Uterus
(A) Ncoa6 IHC (in brown) in Ncoa6f/f and Ncoa6d/d uterine sections. Scale bars represent 100 mm. LE, luminal epithelium; GE, glandular epithelium; St, stroma.
(B) Embryo ISs in Ncoa6f/f uterus (arrows) but not in Ncoa6d/d uterus at 4.5 dpc.
(C) Relative expression levels of P4-regulated genes in Ncoa6
f/f (n = 5) and Ncoa6d/d (n = 5) uteri at 3.5 dpc. *p < 0.05; **p < 0.01; ***p < 0.0001.
(D) Relative expression levels of E2-regulated genes in Ncoa6
f/f (n = 5) and Ncoa6d/d (n = 5) uteri at 3.5 dpc.
(E) Relative expression levels ofMuc1,Hbegf, and Vegfa in the uteri ofNcoa6f/f (n = 5) and Ncoa6d/d (n = 5) mice treated with sesame oil vehicle (V) or low-dose E2
(6.7 ng per mouse).
The data in (C)–(E) are presented as means ± SEM. See also Figure S1.
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Ncoa6, E2 Sensitivity, and Embryo Implantationwild-type (WT) mice (Figures S1A–S1E available online). We next
crossed these mice to PRCre/+ mice (Soyal et al., 2005) and
generated Ncoa6f/f and PRCre/+;Ncoa6f/f (hereinafter designated
as Ncoa6d/d) mice. TotalNcoa6mRNA and protein are abundant
in Ncoa6f/f uteri but are mostly diminished in Ncoa6d/d uteri
(Figures S1F and S1G). In Ncoa6f/f mice, Ncoa6 protein is de-
tected in the uterine luminal and glandular ECs, endometrial
SCs, and myometrial cells. Low-level Ncoa6 protein is also
present in the corpus luteum and fallopian tube. In Ncoa6d/d
mice, Ncoa6 is efficiently knocked out by the expression of
PR-Cre transgene in the uterine ECs and SCs, corpus luteum,
and fallopian tubule epithelium, while Ncoa6 protein is still ex-
pressed in the myometrium where little PR-Cre (Soyal et al.,
2005) is expressed (Figures 1A and S1H–S1J; data not shown).
During breeding with WT male mice for 6 months, 7 Ncoa6f/f
females produced 21 litters with 6.4 ± 2.6 pups per litter, but 9
Ncoa6d/d females did not produce any pups. We next assessed
the effects of Ncoa6 loss on early pregnant events to pursue the
cause of infertility. Ncoa6d/d (versus Ncoa6f/f) mice showed no
significant differences in ovulation (8.4 ± 0.65 oocytes per
mouse, n = 8 versus 7.5 ± 0.4 oocytes per mouse, n = 7), oocyte
fertilization rate (46.4%, n = 69 versus 57.4%, n = 54) at 1.5 dpc,
and blastocyst formation rate at 3.5 dpc (53.6%, n = 28 versusDevelopm69.0%, n = 29). At 3.5 dpc, the serum E2 (185 ± 17 and 173 ±
19 ng/ml, respectively) and P4 (39 ± 4 and 35 ± 1 ng/ml, respec-
tively) levels in Ncoa6d/d (n = 7) and Ncoa6f/f (n = 6) mice are also
similar, indicating a normal luteal function in Ncoa6d/d mice. At
4.5 dpc, we observed normal number of embryo implantation
sites (ISs) (6.8 ± 2.9 per uterus) in Ncoa6f/f uteri (n = 10), but
Ncoa6d/d uteri (n = 10) had no ISs, although 3.3 ± 1.4 unimplanted
normal blastocysts per uterus could be recovered from these
uteri (Figure 1B). Furthermore, transfer of 101 WT blastocysts
into the pseudopregnant Ncoa6f/f uteri (n = 10) generated 41
embryo ISs, but transfer of 87 WT blastocysts into the pseudo-
pregnantNcoa6d/d uteri (n = 8) only produced 1 embryo IS. These
results demonstrate the failure of embryo attachment in
Ncoa6d/d uteri. Therefore, Ncoa6 plays an essential role in the
uterine receptivity for embryo attachment and implantation.
Ncoa6 Deficiency Results in Abnormal Expression
of the Implantation-Related Genes and Increased
E2 Sensitivity in the Uterus
To pursue the cause of implantation failure, we compared the
expression levels of implantation-related genes that are regu-
lated by P4 and E2 (Large and Demayo, 2011; Wang and Dey,
2006) between Ncoa6f/f and Ncoa6d/d uteri at 3.5 dpc. Inental Cell 23, 858–865, October 16, 2012 ª2012 Elsevier Inc. 859
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Ncoa6, E2 Sensitivity, and Embryo ImplantationNcoa6d/d uteri, P4-regulated genes (1) in the epithelium, such as
amphiregulin (Areg) (Ma et al., 2003), lysophosphatidic acid
receptor-3 (Lpar3) (Hama et al., 2006), and Indian hedgehog
(Ihh) (Lee et al., 2006); (2) in both epithelium and stroma, such
as homeobox A10 (Hoxa10) (Cakmak and Taylor, 2011); and (3)
in the stroma, such as heart and neural crest derivatives ex-
pressed 2 (Hand2) (Li et al., 2011), are significantly decreased.
The Ihh-regulated downstream stromal genes such as bone
morphogenetic protein-2 (Bmp2) and chicken ovalbumin
upstream promoter transcription factor 2 (COUP-TFII) (Kurihara
et al., 2007) are also significantly downregulated in Ncoa6d/d
uteri (Figure 1C). On the other hand, E2-regulated genes includ-
ing mucin-1 (Muc1), lactotransferrin (Ltf), heparin-binding EGF-
like factor (Hbegf), vascular endothelial growth factor (Vegfa),
fibroblast growth factors 1/2 (Fgf1/2) and insulin-like growth
factor 1 (Igf1) in Ncoa6d/d uteri are expressed at higher levels
than that in Ncoa6f/f uteri, while the expression of leukemia
inhibitory factor (Lif), a glandular factor that regulates uterine
receptivity, is slightly decreased in Ncoa6d/d uteri (Figure 1D;
and data not shown). These results suggest that Ncoa6
enhances P4-regulated genes but attenuates E2-regulated
genes in the uterus during the preimplantation period under
physiological conditions.
To assess the specific role of Ncoa6 in P4 and E2 signaling
pathways, we treated ovariectomized Ncoa6f/f and Ncoa6d/d
mice with P4 or low-dose E2 (6.7 ng per mouse). P4 treatment
equally induced the expression of P4-regulated genes including
Areg, Ihh, Hoxa10, Bmp2, and COUP-TFII in Ncoa6f/f and
Ncoa6d/d uteri (Figure S1K). Furthermore, at 2.5 dpc when P4 is
dominant and E2 is not secreted, the expression of Ihh mRNA
in Ncoa6f/f and Ncoa6d/d uteri is also similar (Figure S1L). Low-
dose E2 treatment was unable to induce significant expression
of E2-regulated genes such as Muc1, Hbegf, Vegfa, Myc, and
Igf1 in Ncoa6f/f uteri and also incapable to stimulate the growth
of these uteri. On the contrary, the same treatment resulted in
remarkable induction of these E2-regulated genes in Ncoa6
d/d
uteri and uterine weight gain (Figures 1E, S1M, and S1N). More-
over, at 3.5 dpc, the uteri of Ncoa6d/d mice were grossly heavier
than the uteri of Ncoa6f/f mice in response to hormonal stimula-
tion (Figure S1O). These results demonstrate (1) that Ncoa6
does not directly modulate P4 sensitivity but directly suppresses
E2 sensitivity and (2) that the E2 supersensitivity that resulted
from Ncoa6 KO may inhibit uterine receptivity, as high-dose E2
treatment makes the uterus refractory to embryo attachment
(Ma et al., 2003).
Ncoa6 Deficiency Increases Uterine Epithelial
Proliferation, Stromal ERa Protein, and Epithelial E2
Response during the Preimplantation Period
In normal pregnant uteri, SC growth and cessation of EC prolif-
eration assemble a closed linear uterine lumen for blastocyst
attachment. In agreement with this, Ncoa6f/f uteri have closed
lumens at 3.5 dpc. However, Ncoa6d/d uteri display intricately
extended luminal and glandular epithelia that surround the
curving lumens with many branches on the uterine cross-
sections (Figure 2A), suggesting an epithelial overgrowth. Cell
proliferation markers Ki-67 and phospho-histone H3 (pHH3)
are undetectable in the epithelium of Ncoa6f/f uteri at 3.5 dpc.
However, Ncoa6d/d uterine epithelium exhibits robust Ki-67860 Developmental Cell 23, 858–865, October 16, 2012 ª2012 Elsevand pHH3 expression, indicating abnormally sustained EC
proliferation during the preimplantation period (Figures 2B and
Figure S2A). Since the EC proliferation is promoted by E2, the
proliferative epithelium also indicates the excess E2 signaling
caused by Ncoa6 KO.
We further examined ERa in the uterus. In comparison with
Ncoa6f/f uteri, Ncoa6d/d uteri exhibit much stronger stromal
ERa immunostaining at 3.5 dpc (Figure 2C). Western blot anal-
ysis further confirmed an overall 2-fold ERa increase in
Ncoa6d/d versus Ncoa6f/f uteri (Figure 2D). Because stromal
ERa is responsible for E2-induced EC proliferation in normal
uterus (Cooke et al., 1997; Winuthayanon et al., 2010), the
increased ERa may be involved in epithelial overgrowth of
Ncoa6d/d uteri.
E2-induced EC proliferation is originated from stroma and
mediated by the fibroblast growth factors (FGFs)-FGFR-ERK
paracrine signaling pathway (Li et al., 2011). Thus, we investi-
gated the downstream signaling components of ERK in the
epithelium. At 3.5 dpc, numerous phospho-ERK1/2-positive
cells were detected in the epithelium of Ncoa6d/d uteri but
undetectable in the epithelium of Ncoa6f/f uteri (Figure 2E).
Accordingly, the phosphorylated ERa on Ser118, a target site of
phospho-ERK1/2, was not detected in ECs of Ncoa6f/f uteri but
was evidently detected in ECs of Ncoa6d/d uteri at 3.5 dpc (Fig-
ure 2F). Since the Ser118 phosphorylation promotes transcrip-
tional activity of ERa, we analyzed the expression of an ERa
target, Muc1, in the uterine epithelium. Muc1 expression was
markedly increased in Ncoa6d/d uteri versus Ncoa6f/f uteri (Fig-
ure 2G). Since Muc1 is a barrier on the surface of luminal ECs
that prevents embryo attachment, the increased Muc1 may
cause blastocyst attachment failure in Ncoa6d/d uteri.
Ncoa6-Deleted Uteri Fail to Downregulate SRC-3
in the Luminal Epithelium
Since the SRC family coactivators enhance ERa transcriptional
activity (Xu et al., 2009), we compared their expressions in
Ncoa6f/f andNcoa6d/d uteri. In nonpregnant mice, SRC-3 protein
is equally expressed in ECs of both Ncoa6f/f and Ncoa6d/d uteri
throughout the estrous cycle (Figure S2B). At 3.5 dpc, SRC-3
is significantly reduced in the epithelium of Ncoa6f/f uteri, as re-
ported previously in normal uteri (Jeong et al., 2007). However,
high-level SRC-3 is still retained in ECs of Ncoa6d/d uteri (Fig-
ure 2H). SRC-3 mRNA is also significantly increased in Ncoa6d/d
uteri (Figure S2C). The expression levels of SRC-1 and SRC-2
are comparable between Ncoa6f/f and Ncoa6d/d uteri at 3.5
dpc (immunohistochemistry [IHC] data not shown). Since
SRC-3 is a strong coactivator for nuclear receptors including
ERa and other transcription factors such as E2F1, AP-1, and
PEA3 (Xu et al., 2009), these results suggest that SRC-3 overex-
pression may also contribute to the increased E2 sensitivity and
cell proliferation in the epithelium of Ncoa6d/d uteri.
Failure of Decidual Response in Ncoa6d/d Uteri Due
to Reduced Bmp2 Expression
Excess E2 stimulation suppresses SC differentiation and decidu-
alization in human and rat uteri (Basir et al., 2001; Kennedy,
1986). To determine the functional impact of E2 supersensitivity
and its accompanied downregulation of P4 signaling in Ncoa6
d/d
uteri, we performed decidual response assay as described in theier Inc.
Figure 2. Ncoa6 Deficiency Causes Epithelial Overproliferation and Elevation of ERa, Phosphorylated ERa, and Muc1 and SRC-3 Proteins
in the Uterus at 3.5 dpc
(A) H&E-stained Ncoa6f/f and Ncoa6d/d uterine sections.
(B and C) Ki67 IHC for (B) Ki67 and (C) ERa in Ncoa6f/f and Ncoa6d/d uterine sections. The boxed areas in the left panels of (C) are enlarged in the right panels,
which show a stronger ERa immunoreactivity in the stroma of Ncoa6d/d uterus versus Ncoa6f/f uterus.
(D) Representative western blot results for ERa in tissue lysates prepared fromNcoa6f/f andNcoa6d/d uteri. Band intensities were determined by densitometry and
normalized to b-actin. The data are presented as means ± SEM. *p = 0.02.
(E–H) IHC for (E) pERK1/2, (F) S118-phosphorylated ERa (pERa), (G) Muc1, and (H) SRC-3 in Ncoa6f/f and Ncoa6d/d uterine sections. Arrows indicate cell nuclei
with pERa immunoreactivity (F), Muc1 immunoreactivity in the apical membrane of luminal epithelium (G), and SRC-3 immunoreactivity in the nuclei of
luminal ECs (H).
Scale bars indicate 100 mm. See also Figure S2.
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in Ncoa6d/d uteri was diminished, and, accordingly, the decidual
response markers, including alkaline phosphatase activity and
mRNA expression of Bmp2 and follistatin (Fst), were not induced
(Figures S3A–S3D). Interestingly, this failure of decidual
response could be partially restored by administration of exoge-
nous BMP2 protein (Figures S3E and S2F). Therefore, Ncoa6
KO-caused downregulation of Bmp2 expression is partially
responsible for the failure of decidualization in Ncoa6d/d uteri.
Inhibition of ER Function Rescues Embryo Implantation
in Ncoa6d/d Uteri
To test whether suppression of E2 supersensitivity could rescue
implantation failure in Ncoa6d/d uteri, we treated Ncoa6f/f and
Ncoa6d/d mice with a low dose of ER antagonist ICI-182780
(ICI) at 3.0 dpc, the time just before the temporal E2 secretionDevelopmoccurred. At 4.5 dpc, we observed that all Ncoa6f/f uteri (n = 6)
had ISs (6.2 ± 1.0 per uterus), and so did five out of six
Ncoa6d/d uteri (3.2 ± 2.1 per uterus) (Figures 3A and 3B). ICI
treatment also strikingly reducedMuc1 expression in the luminal
ECs of Ncoa6d/d uteri at 4.5 dpc, making its expression similar to
that in the untreated Ncoa6f/f uteri (Figure 3C). These results
demonstrate that the Ncoa6 deficiency-caused E2 supersensi-
tivity is responsible for the implantation failure in Ncoa6d/d uteri.
Ncoa6 Accelerates ERa Ubiquitination and Degradation
In pursuing howERa is increased inNcoa6d/d uteri, wemeasured
itsmRNA levels. ERamRNA is comparably expressed inNcoa6f/f
and Ncoa6d/d uteri at 3.5 dpc (Figure S4A). We then assessed
how Ncoa6 deficiency affected ERa protein stability in uterine
SCs. SCs isolated from Ncoa6d/d uteri at the preimplantation
stage displayed higher levels of ERa protein than those fromental Cell 23, 858–865, October 16, 2012 ª2012 Elsevier Inc. 861
Figure 3. Inhibition of E2 Supersensitivity with ICI-182780 Treatment
Rescues Embryo Implantation in Ncoa6d/d Uteri
(A) ISs (arrows) in Ncoa6f/f and Ncoa6d/d uteri at 4.5 dpc after ICI-182780
treatment.
(B) A H&E-stained embryo (arrow) attached to the epithelium of Ncoa6d/d
uterus at 4.5 dpc in a mouse treated with ICI-182780.
(C) IHC for Muc1 in uterine sections prepared from vehicle (sesame oil)- or
ICI-182780-treated Ncoa6d/d mice and untreated Ncoa6f/f mice at 4.5 dpc.
Arrows indicate Muc1 immunoreactivity located at the surface of luminal ECs.
Scale bars indicate 100 mm. See also Figure S3.
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synthesis was blocked by cyclohexamide (CHX), ERa degraded
slightly faster in Ncoa6f/f SCs versus Ncoa6d/d SCs in the
absence of E2 (Figures 4A and S4B). More interestingly, E2 treat-
ment induced a rapid ERa degradation in Ncoa6f/f SCs but
only slightly accelerated ERa degradation in Ncoa6d/d SCs
(Figures 4B and S4C). Moreover, NCOA6 knockdown and
overexpression in human MCF-7 cells increased and decreased
ERa protein, respectively (Figure S4D; data not shown). These
results suggest that Ncoa6 levels are inversely correlated with
ERa levels.
Next, we examined whether Ncoa6 is involved in ERa ubiqui-
tination-dependent degradation. In Ncoa6f/f uterine SCs, Ncoa6
is associated with ERa in both presence and absence of E2 as
evidenced by coimmunoprecipitation (coIP) (Figure 4C). ERa
ubiquitination is detected at low levels in untreated cells, but it
is significantly induced in E2-treatedNcoa6
f/f cells. Ubiquitinated
ERa further increases after these cells are treated with protea-
some inhibitor MG132, and reaches the peak level upon
combined E2 and MG132 treatment (Figure 4C). However, ubiq-
uitinated ERa is barely detectable in un-treated or E2-treated
Ncoa6d/d SCs. Ubiquitinated ERa is also significantly lower in
MG132-treated and MG132+E2-treated Ncoa6
d/d SCs versus
the same reagents-treated Ncoa6f/f SCs (Figure 4C). Further-
more, both human NCOA6a and NCOA6b isoforms (Li and Xu,
2011) ectopically expressed in HeLa cells form complexes with
ERa and robustly enhance ERa ubiquitination (Figure 4D).
Finally, amino acid sequence analysis suggests that Ncoa6
does not contain any conserved homologous domain to any
ubiquitin ligase, and in vitro ERa ubiquitination and protea-
some-mediated degradation assays using purified human862 Developmental Cell 23, 858–865, October 16, 2012 ª2012 ElsevNCOA6 proteins failed to support it as an E3 ligase (data not
shown). Taken together, these results suggest that Ncoa6 may
serve as a molecular modulator to promote ERa ubiquitination
and degradation. This function of Ncoa6 may suppress E2 sensi-
tivity through downregulation of ERa protein in the uterine
stroma to allow embryo implantation.
DISCUSSION
We have demonstrated that Ncoa6 KO in the uterine SCs and
ECs results in embryo implantation failure, indicating that
Ncoa6 is absolutely required for appropriate development of
uterine endometrial receptivity. Furthermore, Ncoa6 deficiency
robustly increases uterine E2 sensitivity as evidenced by the
increased expression of ERa target genes under physiological
conditions, the abnormally sustained EC proliferation during
the preimplantation period and the supersensitive response to
low dose E2-induced gene expression and uterine growth. More-
over, suppression of ERa function rescues embryo implantation,
proving that E2 supersensitivity is responsible for the failure of
embryo implantation caused by Ncoa6 deficiency. These
discoveries clearly indicate that Ncoa6 actually attenuates
E2/ERa physiological function to permit embryo implantation in
the uterus, although it was previously reported as an ERa coac-
tivator based on experiments performed using cultured cells
(Mahajan and Samuels, 2005). These findings also qualify
Ncoa6 as an essential negative modulator of uterine E2 sensi-
tivity during the preimplantation period.
Since E2-induced uterine EC proliferation is indirectly stimu-
lated by the ERa-mediated FGFs and IGF1 expression in the
stroma and the subsequent paracrine activation of the receptor
tyrosine kinases and downstream protein kinase signaling path-
ways in ECs (Hewitt et al., 2010; Li et al., 2011), the Ncoa6 defi-
ciency-induced uterine E2 supersensitivity should be initiated
from the increased ERa protein in the stroma. Our data, when
combinedwith the existing knowledge, suggest that the increase
in stromal ERa in Ncoa6d/d uteri promotes the expression of
growth factors such as IGF1 and FGFs, which in turn activate
their receptors and downstream protein kinase pathways such
as ERK. ERK-mediated phosphorylation of S118 enhances ERa
activity in ECs. The enhanced ERK pathwaymay also upregulate
SRC-3 through activating the E2F1/SP1–SRC-3 positive feed-
back regulatory loop (Mussi et al., 2006). Since SRC-3 is a potent
ERa coactivator (Xu et al., 2009), the persistent expression of
high level SRC-3 may work synergistically with the activated
ERa in ECs of Ncoa6d/d uteri to support the sustained Muc1
expression at 3.5 dpc, preventing embryo attachment. In addi-
tion, since ERK activation also leads to activation of multiple
transcription factors such as E2F1, AP-1 and PEA3 that use
SRC-3 as a coactivator to promote cell proliferation (Xu et al.,
2009), the upregulated SRC-3 in Ncoa6d/d uteri may be partially
responsible for the sustained EC proliferation at 3.5 dpc, causing
a blockage of EC differentiation.
In early pregnancy, counterbalanced E2 and P4 signaling path-
ways coordinately regulate uterine receptivity. Overstimulation
with E2 dosages that inhibit uterine receptivity has been shown
to inhibit P4/PR signaling (Tibbetts et al., 1998) and downregulate
PR target genes such as Ihh (Matsumoto et al., 2002), Lpar3
(Hama et al., 2006) and Areg (Ma et al., 2003) in the uterineier Inc.
Figure 4. Ncoa6 Enhances ERa Ubiquitina-
tion and Degradation
(A) The isolated Ncoa6f/f and Ncoa6d/d uterine SCs
were cultured in the absence of estrogen and
treated with CHX. Cells were collected at different
time points for western blot.
(B) The aforementioned cells were treated with E2
andCHXas indicatedandassayedbywesternblot.
(C) Ncoa6f/f and Ncoa6d/d uterine SCs were
treated with MG132 and/or E2 as indicated. A
small portion of cell lysate was assayed by
western blot (upper panel). The larger portion of
the cell lysate was subjected to coIP using ERa
antibody, followed by western blot analysis of the
eluates using antibodies against Ncoa6, ubiquitin,
and ERa (lower panels). The amount of sample
loaded was adjusted to comparable input of
precipitated ERa. The immunoglobulin G (IgG)
bands were from the antibody for coIP.
(D) HeLa cells were cotransfected with hER-
a-expressing plasmid and a plasmid expressing
hNCOA6a, hNCOA6b (a splicing isoform without
exon 10), or no protein (control). The transfected
cells were treated with MG132 and/or E2 as
indicated. A small portion of the cell lysate was
assayed by western blot (upper panel). The re-
maining cell lysate was subjected to coIP using
ERa antibody or control IgG. The eluted precipi-
tates were analyzed by western blot for Ncoa6,
HA-ubiquitin, and ERa.
See also Figure S4.
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including Ihh, Areg and Lpar3 in ECs of Ncoa6d/d uteri may be
a result of inhibition from Ncoa6 deficiency-triggered E2 super-
sensitivity. The reduced Ihh expression should explain the
decreased expression of Ihh-inducible genes Bmp2 and
COUP-TFII in the stroma of Ncoa6d/d uteri (Kurihara et al., 2007;
Lee et al., 2010). Since both Bmp2 and COUP-TFII are essential
for uterine decidual response (Kurihara et al., 2007; Lee et al.,
2010), the Ncoa6 deficiency-impaired decidual response should
be caused by the decreased expression of these genes, as evi-
denced by the partial rescue of decidual response in Ncoa6d/d
uteri treated with BMP2 protein. However, the regulatory mecha-
nisms for the decreased expression of Hoxa10 and Hand2 in the
stroma of Ncoa6d/d uteri are currently unclear, which could be
a consequence of impaired uterine receptivity caused by E2
supersensitivity.
In yeast, the 19S components of the 26S proteasome interact
with transcriptional elongation factors to enhance transcription
elongation in an independent manner to their proteolytic roles
(Ferdous et al., 2001). In cultured mammalian cells, E2-bound
ERa recruits coactivators and proteasome components to the
target gene promoters to form a transcriptional activation
complex, in which the proteasome components accelerate tran-
scription by degrading ERa that has finished its transcriptional
activation task, which may be required to reload the next run
of transcriptional initiation (Lonard et al., 2000; Reid et al.,Developmental Cell 23, 858–865,2003). Interestingly, the current study
demonstrates that Ncoa6 interacts with
ERa to accelerate ERa ubiquitinationand proteasome-mediated degradation regardless of E2-binding
status. More importantly, this Ncoa6-associated ERa degrada-
tion plays an essential role to avoid abnormal increase in ERa
protein and thereby prevent the uterus from acquiring E2 super-
sensitivity for appropriate embryo implantation. Therefore,
Ncoa6-accelerated ERa ubiquitination and degradation do not
functionally couple with transcriptional activation but actually
attenuate the expression of ERa target genes in the uterus under
natural conditions.
Increased levels of ERa and SRC-3 expression have been
found in the endometrium of women with PCOS associated
with E2 supersensitivity and poor reproductive performance
(Gregory et al., 2002). Similarly, in Ncoa6d/d mouse uteri,
Ncoa6 deficiency also increases ERa in the stroma and SRC-3
in the epithelium during the preimplantation period and resulted
in E2 supersensitivity and implantation failure. This suggests that
loss of Ncoa6 expression or function might be involved in ERa
and SRC-3 upregulation and E2 supersensitivity observed in
the uteri of women with PCOS.
EXPERIMENTAL PROCEDURES
Mouse Experiments
Animal protocols were approved by the Baylor College of Medicine Animal
Care and Use Committee. PR-Cre mice were described previously (Soyal
et al., 2005). Ncoa6f/f and Ncoa6d/d mice were generated as illustrated in Fig-
ure S1 and the Supplemental Experimental Procedures. For collecting uterineOctober 16, 2012 ª2012 Elsevier Inc. 863
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Ncoa6, E2 Sensitivity, and Embryo Implantationspecimens from pregnant or pseudopregnant mice, 8- to 10-week-old females
were paired with intact or vasectomized WT males. Copulatory plugs were
checked in the morning, and the morning when vaginal plug was observed
was designated as 0.5 dpc. Ovulation and fertilization were examined at
1.5 dpc. The early blastocyst development was examined at 3.5 dpc. ISs
were examined at 4.5 or 5.5 dpc. The serum concentrations of E2 and P4
were measured using blood samples collected at 3.5 dpc. Detail method is
described in the Supplemental Experimental Procedures. For E2 and P4 treat-
ments, 6-week-old female mice were ovariectomized, allowed to rest for
2 weeks, and then subcutaneously injected with vehicle (sesame oil), 6.7 ng
of E2, or 1 mg of P4 in sesame oil per mouse. Six hours later, uteri were
collected, frozen in liquid nitrogen, and stored at 80C for analysis. For ICI
treatment, a previous protocol (Lee et al., 2010) was slightly modified. Each
mouse was intraperitoneally injected with 5 ng of ICI in 200 ml of sesame oil
at 11 pm on 3.0 dpc. ISs were analyzed at 4.5 dpc.
RT-PCR
RNA was isolated from uteri using Trizol reagent and converted to cDNA using
the Reverse Transcriptase Core Kit (Eurogentec). Relative mRNA levels were
measured using matched Universal TaqMan real-time PCR probes (Roche)
and gene-specific primers. Ncoa6 mRNA was measured using the qPCR
Core kit for SYBR Green I (Eurogentec) with matched primers. All probe and
primer sets for quantitative PCR are listed in the Supplemental Experimental
Procedures. 18S RNA was measured using the TaqMan Ribosomal RNA
Control Reagents (Applied Biosystems) and used to normalize relative
mRNA levels in each sample.
Primary Culture of Uterine Stromal Cells
Uterine SCs were isolated from pseudopregnant mice at 3.5 dpc as described
in the Supplemental Experimental Procedures. For analysis of ERa degrada-
tion and ubiquitination, cells were cultured in Dulbecco’s modified Eagle’s
medium/F12 medium with 10% charcoal-stripped FBS for 48 hr and followed
by treatment with reagents as indicated.
IHC
Uterine sections 5 mm thick were prepared from formalin-fixed and paraffin-
embedded tissues and processed for hematoxylin and eosin (H&E) staining
and IHC as described (Lee et al., 2006). Antibodies for IHC are listed in Supple-
mental Experimental Procedures.
Transfection
Plasmid constructs are described in the Supplemental Experimental Proce-
dures. HeLa cells were transfected with plasmids using lipofectamine 2000
(Invitrogen). MCF-7 cells were transfected with plasmids using lipofectamine
LTX (Invitrogen). Total amount of DNA used in each transfection assay was
balanced by adding the pcDNA3 parent plasmid.
Western Blot and CHX Chase
Protein was extracted from whole uterus or cultured cells using RIPA buffer
with proteinase inhibitors and phosphatase inhibitors. Western blotting was
performed with 30 mg of protein in each lysate and antibodies listed in the
Supplemental Experimental Procedures. To assay ERa stability, mouse
uterine SCs were treated with 10 mg/ml of CHX. Thirty minutes after adding
CHX, cells were treated with vehicle (ethanol) or 10 nM of E2. Band intensities
of western blots were quantified by densitometry using Image J software.
ERa Ubiquitination Assay
Mouse uterine SCs were pretreated with vehicle (dimethyl sulfoxide) or 10 mM
of MG132 for 30 min and then treated with vehicle (ethanol) or 10 nM of E2 for
6 hr. HeLa cells were transfected with mock or expression vectors for hERa,
hNCOA6a, hNCOA6b, and HA-ubiquitin. The transfected cells were treated
with vehicle or 10 mM of MG132 for 6.5 hr and with vehicle or 10 nM of E2
for 6 hr (added 0.5 hr later after MG132 addition). The treated cells were lysed
in TNE buffer (10 mM Tris-HCl, pH 7.8, 1% NP40, 0.15 M NaCl, 1 mM EDTA)
containing proteinase inhibitors and phosphatase inhibitors. ERa was immu-
noprecipitated from cell lysate with 500 mg protein using ERa antibody. The
precipitates were assayed by western blots using ERa, ubiquitin, and Ncoa6
antibodies.864 Developmental Cell 23, 858–865, October 16, 2012 ª2012 ElsevStatistical Analysis
Data are presented as means ± SEM. Statistical analyses were performed
using a two-sided unpaired Student’s t test, Mann-Whitney’s U test, one-way
analysis of variance, or analysis of covariance. Multiplicity adjustment
methods (Bonferroni method) were used when multiple pairwise comparisons
were performed. Chi-square tests were used to evaluate differences of data in
percentages.
SUPPLEMENTAL INFORMATION
Supplemental information includes four figures and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.doi.
org/10.1016/j.devcel.2012.09.002.
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